Page last updated: 2024-10-27

gabexate and Nervous System Disorders

gabexate has been researched along with Nervous System Disorders in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wakui, K1
Takemae, T1
Kobayashi, S1
Inuzuka, T1
Sato, S1
Baba, H1
Miyatake, T1

Other Studies

2 other studies available for gabexate and Nervous System Disorders

ArticleYear
[Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
    No shinkei geka. Neurological surgery, 1990, Volume: 18, Issue:7

    Topics: Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Female; Fibrin Fibrinogen D

1990
Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases.
    Acta neurologica Scandinavica, 1987, Volume: 76, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Endopeptidases; Esters; Follow-Up Studies; Gabexate; Guanidines; Huma

1987